Sep 1993;42(9):1217-1222
While it may serve as a complementary option for some individuals with metabolic disorders, it should not replace clinically approved therapies
Observational studies and multinational cohorts have also reported lower risks of HF hospitalization, major cardiovascular events, and all-cause mortality with combined therapy compared with either class alone [28,29,30]
Many patients prefer oral medications or non-injectable weight loss solutions
Vandaele L, Thys M, Bijttebier J, Van Langendonckt A, Donnay I, Maes D, et al
Two: genetic differences lead to lower-than-average amount of glutathione production